|
1
|
Zhang GW, Lin JH, Qian JP and Zhou J:
Identification of risk and prognostic factors for patients with
clonorchiasis-associated intrahepatic cholangiocarcinoma. Ann Surg
Oncol. 21:3628–3637. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel T: Increasing incidence and
mortality of primary intrahepatic cholangiocarcinoma in the United
States. Hepatology. 33:1353–1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown KM, Parmar AD and Geller DA:
Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 23:231–246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawarada Y, Yamagiwa K and Das BC:
Analysis of the relationships between clinicopathologic factors and
survival time in intrahepatic cholangiocarcinoma. Am J Surg.
183:679–685. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dhanasekaran R, Hemming AW, Zendejas I,
George T, Nelson DR, Soldevila-Pico C, Firpi RJ, Morelli G, Clark V
and Cabrera R: Treatment outcomes and prognostic factors of
intrahepatic cholangiocarcinoma. Oncol Rep. 29:1259–1267.
2013.PubMed/NCBI
|
|
7
|
Roayaie S, Guarrera JV, Ye MQ, Thung SN,
Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM and Schwartz ME:
Aggressive surgical treatment of intrahepatic cholangiocarcinoma:
Predictors of outcomes. J Am Coll Surg. 187:365–372. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ,
Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, et al: Intrahepatic
cholangiocarcinoma: Report of 272 patients compared with 5,829
patients with hepatocellular carcinoma. J Cancer Res Clin Oncol.
135:1073–1080. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watanabe M, Furuno N, Goebl M, Go M,
Miyauchi K, Sekiguchi T, Basilico C and Nishimito T: Molecular
cloning of the human gene, CCG2, that complements the BHK-derived
temperature-sensitive cell cycle mutant tsBN63: Identity of CCG2
with the human X chromosomal SCAR/RPS4X gene. J Cell Sci.
100:35–43. 1991.PubMed/NCBI
|
|
10
|
Zinn AR, Alagappan RK, Brown LG, Wool I
and Page DC: Structure and function of ribosomal protein S4 genes
on the human and mouse sex chromosomes. Mol Cell Biol.
14:2485–2492. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watanabe M, Zinn AR, Page DC and Nishimoto
T: Functional equivalence of human X- and Y-encoded isoforms of
ribosomal protein S4 consistent with a role in Turner syndrome. Nat
Genet. 4:268–271. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garand C, Guay D, Sereduk C, Chow D,
Tsofack SP, Langlois M, Perreault E, Yin HH and Lebel M: An
integrative approach to identify YB-1-interacting proteins required
for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer
cells. Cancer Sci. 102:1410–1417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsofack SP, Meunier L, Sanchez L, Madore
J, Provencher D, Mes-Masson AM and Lebel M: Low expression of the
X-linked ribosomal protein S4 in human serous epithelial ovarian
cancer is associated with a poor prognosis. BMC Cancer. 13:3032013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paquet ÉR, Hovington H, Brisson H, Lacombe
C, Larue H, Têtu B, Lacombe L, Fradet Y and Lebel M: Low level of
the X-linked ribosomal protein S4 in human urothelial carcinomas is
associated with a poor prognosis. Biomark Med. 9:187–197. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Albanghali M, Green A, Rakha E,
Aleskandarany M, Nolan C, Ellis I and Cheung KL: Construction of
tissue microarrays from core needle biopsy-a systematic literature
review. Histopathology. 68:323–332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan D, Li Q, Deeb G, Ramnath N, Slocum HK,
Brooks J, Cheney R, Wiseman S, Anderson T and Loewen G: Thyroid
transcription factor-1 expression prevalence and its clinical
implications in non-small cell lung cancer: A high-throughput
tissue microarray and immunohistochemistry study. Hum Pathol.
34:597–604. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu
H, Liu XH, Yan GQ, Zhang L, Zhang Y, et al: iTRAQ-2DLC-ESI-MS/MS
based identification of a new set of immunohistochemical biomarkers
for classification of dysplastic nodules and small hepatocellular
carcinoma. J Proteome Res. 10:3418–3428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sang H, Li T, Li H and Liu J: Gab1
regulates proliferation and migration through the PI3K/Akt
signaling pathway in intrahepatic cholangiocarcinoma. Tumour Biol.
36:8367–8377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hyder O, Hatzaras I, Sotiropoulos GC, Paul
A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM,
Aldrighetti L, et al: Recurrence after operative management of
intrahepatic cholangiocarcinoma. Surgery. 153:811–818. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ali SM, Clark CJ, Zaydfudim VM, Que FG and
Nagorney DM: Role of major vascular resection in patients with
intrahepatic cholangiocarcinoma. Ann Surg Oncol. 20:2023–2028.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Jong MC, Nathan H, Sotiropoulos GC,
Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM,
Aldrighetti L, et al: Intrahepatic cholangiocarcinoma: An
international multi-institutional analysis of prognostic factors
and lymph node assessment. J Clin Oncol. 29:3140–3145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ribero D, Pinna AD, Guglielmi A, Ponti A,
Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis
M, et al: Surgical approach for long-term survival of patients with
intrahepatic cholangiocarcinoma: A multi-institutional analysis of
434 patients. Arch Surg. 147:1107–1113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo X, Yuan L, Wang Y, Ge R, Sun Y and Wei
G: Survival outcomes and prognostic factors of surgical therapy for
all potentially resectable intrahepatic cholangiocarcinoma: A large
single-center cohort study. J Gastrointest Surg. 18:562–572. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maithel SK, Gamblin TC, Kamel I,
Corona-Villalobos CP, Thomas M and Pawlik TM: Multidisciplinary
approaches to intrahepatic cholangiocarcinoma. Cancer.
119:3929–3942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weber SM, Ribero D, O'Reilly EM, Kokudo N,
Miyazaki M and Pawlik TM: Intrahepatic Cholangiocarcinoma: Expert
consensus statement. HPB (Oxford). 17:669–680. 2015. View Article : Google Scholar : PubMed/NCBI
|
